Do All High- and Intermediate-Risk Patients With Metastatic Castration-Resistant Prostate Cancer Really Benefit From Abiraterone? [CORRESPONDENCE]
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Addeo, Bahl Tags: CORRESPONDENCE Source Type: research